General Pharmaceutical Council

organization

Last mentioned: Mar 17, 2026

Timeline

  1. Final Call to Action

    MSP urges colleagues to 'rise to the challenge' ahead of the definitive Stage 3 vote.

  2. Committee Stage

    Health and Sport Committee completes evidence gathering from medical and legal experts.

  3. Bill Introduced

    The formal Assisted Dying for Terminally Ill Adults (Scotland) Bill is introduced to Parliament.

  4. Consultation Launched

    Liam McArthur MSP launches the public consultation for the assisted dying bill.

Stories mentioning General Pharmaceutical Council 1

pharma Neutral

Scotland Approaches Historic Final Vote on Assisted Dying Legislation

A Member of the Scottish Parliament has issued a final call for colleagues to support the Assisted Dying for Terminally Ill Adults Bill ahead of a decisive vote. The legislation, if passed, would establish a regulated framework for end-of-life medication, carrying significant implications for healthcare providers and the pharmaceutical supply chain.

11 sources

About General Pharmaceutical Council coverage

This page surfaces every story mentioning General Pharmaceutical Council across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where General Pharmaceutical Council was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.